documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
448 rows where agency_id = "FDA" and posted_year = 1996 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Notice 308
- Other 74
- Supporting & Related Material 55
- Proposed Rule 10
- Rule 1
posted_year 1
- 1996 · 448 ✖
agency_id 1
- FDA · 448 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1980-N-0067-0002 | FDA | Vaginal Contraceptive Drug Products for OTC Use FDA-1980-N-0067 | Vaginal Contraceptive Drug Products for Over-the-Counter Human Use; Reopening of the Administrative Record | Notice | General Notice | 1996-12-26T05:00:00Z | 1996 | 12 | 1996-12-26T05:00:00Z | 1997-03-04T04:59:59Z | 2022-06-08T12:57:16Z | 96-32273 | 0 | 0 | 09000064805bb035 |
| FDA-1996-P-0042-0001 | FDA | Require generic clonazepam prods meet the same dissolution q FDA-1996-P-0042 | Acknowledgement Letter from FDA DMB to Hoffmann-La Roche, Inc | Other | ACK-Acknowledgement Letter | 1996-12-26T05:00:00Z | 1996 | 12 | 2024-07-20T18:43:52Z | 0 | 0 | 09000064804fc613 | |||
| FDA-1996-N-0050-0001 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | FDA | Notice | NAP-Advanced Notice of Proposed Rulemaking | 1996-12-23T05:00:00Z | 1996 | 12 | 1996-12-23T05:00:00Z | 1997-02-28T04:59:59Z | 2008-05-16T22:17:18Z | 0 | 0 | 09000064804fc9af | |
| FDA-1996-P-0016-0007 | FDA | Amend 'Healthy' Definition re: Sodium Levels FDA-1996-P-0016 | HFA-305 to ConAgra, Inc. | Other | ACK-Acknowledgement Letter | 1996-12-23T05:00:00Z | 1996 | 12 | 2008-05-16T22:19:43Z | 0 | 0 | 09000064804fa34c | |||
| FDA-1980-N-0074-0051 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | Anticaries Drug Products for Over-the-Counter Human Use; Partial Stay of Final Rule; Enforcement Policy | Notice | Notice of Stay of Action | 1996-12-20T05:00:00Z | 1996 | 12 | 2022-05-11T16:57:46Z | 0 | 0 | 09000064805bb47c | |||
| FDA-1995-S-0039-0027 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 1996-12-17T05:00:00Z | 1996 | 12 | 2008-09-28T04:00:00Z | 2016-09-30T14:19:46Z | 0 | 0 | 090000648055c2e4 | ||
| FDA-1995-S-0039-0019 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report | 1996-12-12T05:00:00Z | 1996 | 12 | 2008-09-28T04:00:00Z | 2016-09-30T14:19:41Z | 0 | 0 | 090000648055c2e2 | ||
| FDA-1995-S-0039-0026 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Attachment "Pao V: A New Dietary Ingredient Information File"/Reference 1 "Pao V Composition" Report from FDA/CFSAN | Supporting & Related Material | Background Material | 1996-12-12T05:00:00Z | 1996 | 12 | 2016-09-30T14:19:46Z | 0 | 0 | 090000648055c2df | |||
| FDA-1995-S-0039-0025 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Attachment "Pao V: A New Dietary Ingredient Information File-Table of Contents" Report from FDA/CFSAN | Supporting & Related Material | Background Material | 1996-12-12T05:00:00Z | 1996 | 12 | 2016-09-30T14:19:45Z | 0 | 0 | 090000648055c2cd | |||
| FDA-1996-N-0037-0001 | FDA | Review of Clinical Safety Data/Marketing Applications FDA-1996-N-0037 | FDA | Notice | NM-Notice of Meeting | 1996-12-06T05:00:00Z | 1996 | 12 | 1996-12-06T05:00:00Z | 1997-02-01T04:59:59Z | 2008-05-16T22:17:08Z | 0 | 0 | 09000064804fc52b | |
| FDA-1993-G-0001-0003 | FDA | Lactate is GRAS as a Color Fixative in Black Olives FDA-1993-G-0001 | FDA | Notice | NCD-Notice of Confirmation of Effective Date | 1996-12-05T05:00:00Z | 1996 | 12 | 2008-05-16T23:23:41Z | 0 | 0 | 09000064804f9989 | |||
| FDA-1996-N-0050-0012 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:18Z | 0 | 0 | 09000064804fca9a | |||
| FDA-1996-N-0050-0011 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:18Z | 0 | 0 | 09000064804fca98 | |||
| FDA-1996-N-0050-0010 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:17Z | 0 | 0 | 09000064804fca96 | |||
| FDA-1996-N-0050-0008 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:17Z | 0 | 0 | 09000064804fca93 | |||
| FDA-1996-N-0050-0013 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:18Z | 0 | 0 | 09000064804fca9d | |||
| FDA-1996-N-0050-0009 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:19Z | 0 | 0 | 09000064804fca94 | |||
| FDA-1996-N-0050-0003 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:19Z | 0 | 0 | 09000064804fca8e | |||
| FDA-1996-N-0050-0014 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:18Z | 0 | 0 | 09000064804fcaa1 | |||
| FDA-1996-N-0050-0005 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:17Z | 0 | 0 | 09000064804fca90 | |||
| FDA-1996-N-0050-0006 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:17Z | 0 | 0 | 09000064804fca91 | |||
| FDA-1996-N-0050-0007 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:18Z | 0 | 0 | 09000064804fca92 | |||
| FDA-1996-N-0050-0004 | FDA | Regulations of Medical Foods FDA-1996-N-0050 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-11-29T05:00:00Z | 1996 | 11 | 2008-05-16T22:17:18Z | 0 | 0 | 09000064804fca8f | |||
| FDA-1988-P-0024-0001 | FDA | Section 513(E) reclassification of lipectomy systems-CLOSED FDA-1988-P-0024 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-11-19T05:00:00Z | 1996 | 11 | 1996-11-19T05:00:00Z | 1997-02-12T04:59:59Z | 2008-05-30T22:53:00Z | 0 | 0 | 09000064804762e4 | |
| FDA-1978-N-0018-0425 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA CDER to Johnson & Johnson Consumer Products, Inc. | Other | Letter(s) | 1996-11-15T05:00:00Z | 1996 | 11 | 2019-08-28T12:39:34Z | 0 | 0 | 090000648055a5d5 | |||
| FDA-1994-P-0033-0001 | FDA | Establish the Proper Composition of Conjugated Estrogens-CLOSED FDA-1994-P-0033 | FDA | Notice | N-Notice | 1996-11-13T05:00:00Z | 1996 | 11 | 1996-11-13T05:00:00Z | 1996-12-10T04:59:59Z | 2008-05-16T23:19:09Z | 0 | 0 | 09000064804fd433 | |
| FDA-1996-P-0015-0002 | FDA | Bioequivalence Req. for Asacol Delayed-Release Tablets-CLOSED FDA-1996-P-0015 | Acknowledgment Letter from FDA DMB to Procter & Gamble Pharmaceuticals | Other | Acknowledgement Letter/Receipt | 1996-11-06T05:00:00Z | 1996 | 11 | 2024-12-18T21:48:26Z | 0 | 0 | 09000064804f9d67 | |||
| FDA-1996-A-0054-0002 | FDA | Eastlon PET Staple Fiber Complies with Applicable Regulations; Appropriate for Safe Use FDA-1996-A-0054 | Advisory Opinion Denial Response Letter from FDA ORA to Far Eastern Textile Ltd. | Other | Denial | 1996-11-01T05:00:00Z | 1996 | 11 | 2018-03-19T16:29:34Z | 0 | 0 | 09000064804fd2d9 | |||
| FDA-1996-A-0054-0003 | FDA | Eastlon PET Staple Fiber Complies with Applicable Regulations; Appropriate for Safe Use FDA-1996-A-0054 | Advisory Opinion Denial Response Letter from FDA ORA to Far Eastern Textile Ltd. | Other | Denial | 1996-11-01T05:00:00Z | 1996 | 11 | 2024-07-01T19:37:18Z | 0 | 0 | 09000064804fd2da | |||
| FDA-1996-A-0054-0001 | FDA | Eastlon PET Staple Fiber Complies with Applicable Regulations; Appropriate for Safe Use FDA-1996-A-0054 | Advisory Opinion Denial Response Letter from FDA ORA to Far Eastern Textile Ltd. | Other | Denial | 1996-11-01T05:00:00Z | 1996 | 11 | 2024-07-01T19:36:53Z | 0 | 0 | 09000064804fd2d3 | |||
| FDA-1996-P-0015-0001 | FDA | Bioequivalence Req. for Asacol Delayed-Release Tablets-CLOSED FDA-1996-P-0015 | Acknowledgment Letter from FDA DMB to Procter & Gamble Pharmaceuticals | Other | Acknowledgement Letter/Receipt | 1996-10-31T05:00:00Z | 1996 | 10 | 2024-12-18T21:44:30Z | 0 | 0 | 09000064804f9cd0 | |||
| FDA-1996-N-0027-0003 | FDA | National Environmental Policy Act Proposed Revision of Policies and Procedures FDA-1996-N-0027 | National Environmental Policy Act Proposed Revision of Policies and Procedures Reopening Comment Period as to Specific Documents | Proposed Rule | Notice of Extension | 1996-10-22T04:00:00Z | 1996 | 10 | 1996-10-22T04:00:00Z | 1996-11-22T04:59:59Z | 2014-01-20T02:02:05Z | 0 | 0 | 09000064804fb5fd | |
| FDA-1996-V-0017-0002 | FDA | Variance for High Light Laser System Model K333 FDA-1996-V-0017 | Acknowledgement Letter to TriLasers | Other | ACK-Acknowledgement Letter | 1996-10-18T04:00:00Z | 1996 | 10 | 2008-10-30T14:11:12Z | 0 | 0 | 09000064804fa476 | |||
| FDA-1996-N-0049-0001 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-10-17T04:00:00Z | 1996 | 10 | 1996-10-17T04:00:00Z | 1997-01-14T04:59:59Z | 2008-05-16T22:17:12Z | 0 | 0 | 09000064804fc7ee | |
| FDA-1996-M-0019-0003 | FDA | Approval of Prosthesis for Endourethral Prosthesis FDA-1996-M-0019 | American Medical Systems, Inc.; Premarket Approval of UroLume TM Endourethral Prosthesis | Notice | Notice of Approval | 1996-10-17T04:00:00Z | 1996 | 10 | 1996-10-17T04:00:00Z | 1996-11-09T04:59:59Z | 2024-08-20T12:57:36Z | 0 | 0 | 09000064804fa56c | |
| FDA-1996-M-0019-0001 | FDA | Approval of Prosthesis for Endourethral Prosthesis FDA-1996-M-0019 | American Medical Systems, Inc.; Premarket Approval of UroLume TM Endourethral Prosthesis | Notice | Notice of Approval | 1996-10-17T04:00:00Z | 1996 | 10 | 1996-10-17T04:00:00Z | 1996-11-09T04:59:59Z | 2024-08-20T12:56:53Z | 0 | 0 | 09000064804fa569 | |
| FDA-1996-M-0019-0002 | FDA | Approval of Prosthesis for Endourethral Prosthesis FDA-1996-M-0019 | American Medical Systems, Inc.; Premarket Approval of UroLume TM Endourethral Prosthesis | Notice | Notice of Approval | 1996-10-17T04:00:00Z | 1996 | 10 | 1996-10-17T04:00:00Z | 1996-11-09T04:59:59Z | 2024-08-20T12:57:15Z | 0 | 0 | 09000064804fa56a | |
| FDA-1978-N-0018-0424 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Transcript of Public Meeting to Discuss the Photochemistry and Photobiology of Sunscreen, Thursday, September 19, 1996 8:30 a.m., pgs. 1-100 (Vol. 1 of 3) | Other | Transcript(s) | 1996-10-16T04:00:00Z | 1996 | 10 | 2019-07-26T17:57:30Z | 0 | 0 | 090000648055a5c8 | |||
| FDA-1978-N-0018-0423 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Pages 101-206 re: Transcript of Public Meeting to Discuss the Photochemistry and Photobiology of Sunscreen, Friday, September 20, 1996 8:30 a.m. (Vol. 2 of 3) | Supporting & Related Material | Transcript(s) | 1996-10-16T04:00:00Z | 1996 | 10 | 2019-07-29T14:51:42Z | 0 | 0 | 090000648055a5c7 | |||
| FDA-1978-N-0018-0421 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Pages 201-240 re: Transcript of Public Meeting to Discuss the Photochemistry and Photobiology of Sunscreen, Thursday, September 19, 1996 8:30 a.m., (Vol. 1 of 3) | Supporting & Related Material | Transcript(s) | 1996-10-16T04:00:00Z | 1996 | 10 | 2019-07-29T14:44:55Z | 0 | 0 | 090000648055a5c5 | |||
| FDA-1978-N-0018-0417 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Pages 101-200 re: Transcript of Public Meeting to Discuss the Photochemistry and Photobiology of Sunscreen, Thursday, September 19, 1996 8:30 a.m. (Vol. 1 of 3) | Supporting & Related Material | Transcript(s) | 1996-10-16T04:00:00Z | 1996 | 10 | 2019-07-29T14:46:57Z | 0 | 0 | 090000648055a5c1 | |||
| FDA-1978-N-0018-0418 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Requirements For the Radicals to be Significant re: Transcript of Public Meeting to Discuss the Photochemistry and Photobiology of Sunscreen, Thursday, September 19, 1996 8:30 a.m (Vol. 3 of 3) | Supporting & Related Material | Background Material | 1996-10-16T04:00:00Z | 1996 | 10 | 2019-08-02T15:11:02Z | 0 | 0 | 090000648055a5c2 | |||
| FDA-1978-N-0018-0419 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Sunscreen Efficacy re: Transcript of Public Meeting to Discuss the Photochemistry and Photobiology of Sunscreen, Thursday, September 19, 1996 8:30 a.m (Vol. 3 of 3) | Supporting & Related Material | Background Material | 1996-10-16T04:00:00Z | 1996 | 10 | 2019-08-02T15:06:49Z | 0 | 0 | 090000648055a5c3 | |||
| FDA-1996-P-0309-0005 | FDA | Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 | Supplement from Andes Candies, Inc., Nutrition Research Group (NRG) | Other | Supplement (SUP) | 1996-10-16T04:00:00Z | 1996 | 10 | 2014-02-20T05:00:00Z | 2014-02-20T12:05:16Z | 0 | 0 | 0900006480504c77 | ||
| FDA-1978-N-0018-0422 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Pages 1-100 re: Transcript of Public Meeting to Discuss the Photochemistry and Photobiology of Sunscreen, Friday, September 20, 1996 8:30 a.m. (Vol. 2 of 3) | Supporting & Related Material | Transcript(s) | 1996-10-16T04:00:00Z | 1996 | 10 | 2019-07-29T14:49:05Z | 0 | 0 | 090000648055a5c6 | |||
| FDA-1978-N-0018-0420 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Spectroscopic Properties of Titania, Dated 09/19-20/1996 re: Transcript of Public Meeting to Discuss the Photochemistry and Photobiology of Sunscreen, Thursday, September 19, 1996 8:30 a.m (Vol. 3 of 3) | Supporting & Related Material | Background Material | 1996-10-16T04:00:00Z | 1996 | 10 | 2019-08-02T14:58:43Z | 0 | 0 | 090000648055a5c4 | |||
| FDA-1980-N-0074-0049 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association | Other | LET-Letter | 1996-10-15T04:00:00Z | 1996 | 10 | 2022-05-09T20:53:16Z | 0 | 0 | 09000064805bb476 | |||
| FDA-1996-N-0049-0009 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:12Z | 0 | 0 | 09000064804fc989 | |||
| FDA-1996-N-0049-0014 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:13Z | 0 | 0 | 09000064804fc98f | |||
| FDA-1996-N-0049-0008 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:12Z | 0 | 0 | 09000064804fc988 | |||
| FDA-1996-N-0049-0002 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:14Z | 0 | 0 | 09000064804fc982 | |||
| FDA-1996-N-0049-0011 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:14Z | 0 | 0 | 09000064804fc98c | |||
| FDA-1980-N-0074-0050 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association | Other | Letter(s) | 1996-10-15T04:00:00Z | 1996 | 10 | 2022-05-10T18:15:02Z | 0 | 0 | 09000064805bb477 | |||
| FDA-1996-N-0049-0013 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:16Z | 0 | 0 | 09000064804fc98e | |||
| FDA-1996-N-0049-0010 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:14Z | 0 | 0 | 09000064804fc98a | |||
| FDA-1996-N-0049-0007 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:12Z | 0 | 0 | 09000064804fc987 | |||
| FDA-1996-N-0049-0012 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:11Z | 0 | 0 | 09000064804fc98d | |||
| FDA-1996-N-0049-0005 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:14Z | 0 | 0 | 09000064804fc985 | |||
| FDA-1996-N-0049-0006 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:14Z | 0 | 0 | 09000064804fc986 | |||
| FDA-1996-N-0049-0003 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:13Z | 0 | 0 | 09000064804fc983 | |||
| FDA-1996-N-0049-0004 | FDA | OTC-Colloidal Silver Ingredients or Silver Salts FDA-1996-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1996-10-15T04:00:00Z | 1996 | 10 | 2008-05-16T22:17:11Z | 0 | 0 | 09000064804fc984 | |||
| FDA-1996-N-0006-0001 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System; Request for Information and Comments | Proposed Rule | Advance Notice of Proposed Rulemaking (ANPRM) | 1996-10-11T04:00:00Z | 1996 | 10 | 1996-10-11T04:00:00Z | 1997-01-03T04:59:59Z | 2015-06-30T01:30:43Z | 0 | 0 | 09000064804f991c | |
| FDA-1990-N-0002-0009 | FDA | Revise Medical Device CGMP Regulation FDA-1990-N-0002 | FDA | Notice | NFR-Notice of Final Rule | 1996-10-11T04:00:00Z | 1996 | 10 | 1996-10-11T04:00:00Z | 1996-12-07T04:59:59Z | 2008-05-16T23:46:16Z | 0 | 0 | 0900006480525806 | |
| FDA-1980-N-0074-0048 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | Anticaries Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment; Partial Delay of Effective Date | Notice | General Notice | 1996-10-11T04:00:00Z | 1996 | 10 | 2022-05-09T20:45:25Z | 0 | 0 | 09000064805bb475 | |||
| FDA-1990-N-0002-0010 | FDA | Revise Medical Device CGMP Regulation FDA-1990-N-0002 | FDA | Notice | NFR-Notice of Final Rule | 1996-10-11T04:00:00Z | 1996 | 10 | 1996-10-11T04:00:00Z | 1996-12-07T04:59:59Z | 2008-05-16T23:46:04Z | 0 | 0 | 090000648052580a | |
| FDA-1990-N-0002-0008 | FDA | Revise Medical Device CGMP Regulation FDA-1990-N-0002 | FDA | Notice | NFR-Notice of Final Rule | 1996-10-11T04:00:00Z | 1996 | 10 | 1996-10-11T04:00:00Z | 1996-12-07T04:59:59Z | 2008-05-16T23:46:14Z | 0 | 0 | 0900006480525802 | |
| FDA-1980-N-0074-0047 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | Letter from FDA HFD-560 to Jane Baluss-Buc & Beardsley | Other | Letter(s) | 1996-10-07T04:00:00Z | 1996 | 10 | 2022-05-09T20:12:01Z | 0 | 0 | 09000064805bb474 | |||
| FDA-1996-P-0246-0004 | FDA | Establishes RACCs for Various Types of Food Products Candies FDA-1996-P-0246 | Supplement from Chocolate Manufacturers Association (CMA) and National Confectioners Association (NCA) | Other | Supplement (SUP) | 1996-10-02T04:00:00Z | 1996 | 10 | 2014-02-20T05:00:00Z | 2014-02-20T13:40:29Z | 0 | 0 | 0900006480503973 | ||
| FDA-1996-P-0021-0001 | FDA | ANDA for a delayed-release cap. of Diclofenac Sodium 50 mg.-CLOSED FDA-1996-P-0021 | Acknowledgement Letter from FDA/DMB to Carlsbad Technology, Inc. | Other | Acknowledgement Letter/Receipt | 1996-10-02T04:00:00Z | 1996 | 10 | 2024-12-13T21:54:42Z | 0 | 0 | 09000064804fa6c2 | |||
| FDA-1990-N-0002-0007 | FDA | Revise Medical Device CGMP Regulation FDA-1990-N-0002 | FDA | Notice | NM-Notice of Meeting | 1996-09-25T04:00:00Z | 1996 | 9 | 2008-05-16T23:46:04Z | 0 | 0 | 0900006480525800 | |||
| FDA-1978-N-0018-0177 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:59Z | 0 | 0 | 090000648055a36c | |
| FDA-1978-N-0018-0183 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:03Z | 0 | 0 | 090000648055a37a | |
| FDA-1978-N-0018-0391 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:24Z | 0 | 0 | 090000648055a59e | |
| FDA-1978-N-0018-0399 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:47Z | 0 | 0 | 090000648055a5a7 | |
| FDA-1978-N-0018-0416 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:47Z | 0 | 0 | 090000648055a5b9 | |
| FDA-1978-N-0018-0297 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:00Z | 0 | 0 | 090000648055a4ab | |
| FDA-1978-N-0018-0312 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:33Z | 0 | 0 | 090000648055a4e0 | |
| FDA-1978-N-0018-0321 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:03Z | 0 | 0 | 090000648055a4fe | |
| FDA-1978-N-0018-0331 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:12Z | 0 | 0 | 090000648055a51c | |
| FDA-1978-N-0018-0340 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:00Z | 0 | 0 | 090000648055a535 | |
| FDA-1978-N-0018-0156 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:23Z | 0 | 0 | 090000648055a33d | |
| FDA-1978-N-0018-0191 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:59Z | 0 | 0 | 090000648055a38d | |
| FDA-1978-N-0018-0410 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:47Z | 0 | 0 | 090000648055a5b2 | |
| FDA-1978-N-0018-0362 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:55:46Z | 0 | 0 | 090000648055a568 | |
| FDA-1978-N-0018-0368 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:12Z | 0 | 0 | 090000648055a576 | |
| FDA-1978-N-0018-0245 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:24Z | 0 | 0 | 090000648055a40a | |
| FDA-1978-N-0018-0248 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:55:46Z | 0 | 0 | 090000648055a410 | |
| FDA-1978-N-0018-0229 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:55:46Z | 0 | 0 | 090000648055a3e8 | |
| FDA-1978-N-0018-0240 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:18Z | 0 | 0 | 090000648055a3ff | |
| FDA-1978-N-0018-0241 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:18Z | 0 | 0 | 090000648055a401 | |
| FDA-1978-N-0018-0243 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:24Z | 0 | 0 | 090000648055a406 | |
| FDA-1978-N-0018-0168 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:12Z | 0 | 0 | 090000648055a358 | |
| FDA-1978-N-0018-0169 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:03Z | 0 | 0 | 090000648055a35a | |
| FDA-1978-N-0018-0249 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:12Z | 0 | 0 | 090000648055a413 | |
| FDA-1978-N-0018-0264 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:12Z | 0 | 0 | 090000648055a436 | |
| FDA-1978-N-0018-0272 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:18Z | 0 | 0 | 090000648055a44a | |
| FDA-1978-N-0018-0275 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:33Z | 0 | 0 | 090000648055a467 | |
| FDA-1978-N-0018-0277 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:59Z | 0 | 0 | 090000648055a46b | |
| FDA-1978-N-0018-0294 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:56:18Z | 0 | 0 | 090000648055a49f | |
| FDA-1978-N-0018-0295 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1996-09-23T04:00:00Z | 1996 | 9 | 1996-09-23T04:00:00Z | 1996-10-17T03:59:59Z | 2008-05-30T22:57:12Z | 0 | 0 | 090000648055a4a4 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);